Benjamin is an associate in the Corporate Department of our Hong Kong office. He specialises in capital market transactions, mergers and acquisitions, investment deals, banking and structured finance and general corporate and commercial matters, as well as the structuring, formation, regulation and ongoing operation of investment funds. Ben is fluent in English, Mandarin and Cantonese.
Benjamin Tao
Associate
Overview
Expertise
- Corporate and commercial
- Corporate finance
- Investment funds
- Mergers and acquisitions
- Banking and structured finance
Qualifications and Admissions
- Registered Foreign Lawyer, Hong Kong, 2025
- Admitted in the British Virgin Islands, 2024
- Solicitor of the Senior Courts of England & Wales (non-practising), 2024
- Solicitor of High Court of Hong Kong SAR (non-practising), 2020
- Postgraduate Certificate in Law, City University of Hong Kong, 2017
- Bachelor of Laws, University of Exeter, 2016
- Bachelor of Psychology and Economics, University of Exeter, 2014
Publications and News
News
- Campbells contributes to record CSX performance in 2025.
The CSX delivered another strong year in 2025 and Campbells is proud to be the largest referrer of Funds listings from Hong Kong. - Campbells advises ChinaAMC Core Income Bond Fund SP on its listing on the Cayman Islands Stock Exchange.
Campbells acted as Cayman Islands legal counsel for ChinaAMC Segregated Portfolio Company II on the listing of its segregated portfolio, ChinaAMC Core Income Bond Fund SP, on the Cayman Islands Stock Exchange. - Campbells advises Ridge Outdoor International Limited on its listing on the Main Board of HKEX.
Campbells acted as Cayman Islands legal counsel to Ridge Outdoor International Limited in connection with its close to HK$350 million initial public offering and listing of its 28,205,000 shares on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX). - Campbells advises Distinct Healthcare Holdings Limited on its listing on the Main Board of HKEX.
Campbells acted as Cayman Islands legal counsel to Distinct Healthcare Holdings Limited in connection with its close to HK$290 million initial public offering and listing of its 4,750,000 shares on The Hong Kong Stock Exchange.